Verapamil Hydrochloride
- Product NDC
- 70771-1602
- 11-digit product format
- 707711602
- Labeler code
- 70771
- Product ID
- 70771-1602_f1081c30-3025-42ce-b222-824630689bb8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Verapamil Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA214215
- Marketing category
- ANDA
- Marketing start
- 2020-10-22
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 2.5 mg/mL
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70771-1602-5 | 70771160205 | 5 VIAL in 1 CARTON (70771-1602-5) / 4 mL in 1 VIAL (70771-1602-1) | 5 vial | 2020-10-22 | No | No | Historical |